Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Kronos Bio, Inc. (KRON)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-05-19Dec-31-18Dec-05-18
   10-K10-K10-K10-KS-1/A10-KS-1/A
Revenue      13.4 5.0
            Revenue growth      167.2%  
Operating expenses:         
Research and development  93.7112.943.313.4 5.0 
General and administrative  43.438.514.83.43.41.61.6
    Total operating expenses  137.1151.458.016.816.86.66.6
    Loss from operations  -137.1-151.4-58.0-16.8-16.8-6.6-6.6
   
Other income (expense), net:         
Interest and other income, net  3.90.30.90.7   
    Total other income (expense), net  3.90.3-30.40.7 -0.1 
    Net loss  -133.2-151.1-88.4-16.1-16.1-6.7-6.7
   
Other comprehensive income (loss):         
Net unrealized gain (loss) on available-for-sale securities  -0.80.0     
    Net comprehensive loss  -134.0-151.1-88.4-16.1 -6.7 
   
Net loss per share, basic (in dollars per share)  ($2.37)($2.76)($5.43)($3.05)($3.05)($1.38)($1.38)
Net loss per share, diluted (in dollars per share)  ($2.37)($2.76)($5.43)($3.05)($3.05)($1.38)($1.38)
   
Weighted-average shares of common stock, basic (in shares)  56.254.816.35.35.34.94.9
Weighted-average shares of common stock, diluted (in shares)  56.254.8     

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy